The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits

Piotr Kozlowski1 Department of Medicine, School of Medical Sciences, Örebro University, Örebro, SwedenCorrespondence[email protected]

Scott Montgomery2 Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden;3 Clinical Epidemiology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden;4 Department of Epidemiology and Public Health, University College London, London, UK

Rahel Befekadu5 Department of Transfusion Medicine, School of Medical Sciences, Örebro University, Örebro, Sweden

Victoria Hahn-Strömberg6 Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden

Pages 29-34 | Published online: 06 Mar 2017

Cite this article
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KyleRAGertzMAPrimary systemic amyloidosis: clinical and laboratory features in 474 casesSemin Hematol199532145597878478
PubMed Web of Science ®Google Scholar
CowanAJSeldinDCSkinnerMAmyloid deposits in the bone marrow of patients with immunoglobulin light chain amyloidosis do not impact stem cell mobilization or engraftmentBiol Blood Marrow Transplant201218121935193822842332
PubMed Web of Science ®Google Scholar
KyleRAGertzMAWitzigTEReview of 1027 patients with newly diagnosed multiple myelomaMayo Clin Proc2003781213312528874
PubMed Web of Science ®Google Scholar
NasrSHValeriAMSethiSClinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsiesAm J Kidney Dis201259678679422417785
PubMed Web of Science ®Google Scholar
MontsenyJJKleinknechtDMeyrierALong-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathiesNephrol Dial Transplant1998136143814459641173
PubMed Web of Science ®Google Scholar
GerthJSachseABuschMScreening and differential diagnosis of renal light chain-associated diseasesKidney Blood Press Res201235212012822056791
PubMed Web of Science ®Google Scholar
SwanNSkinnerMO’HaraCJBone marrow core biopsy specimens in AL (primary) amyloidosis. A morphologic and immunohistochemical study of 100 casesAm J Clin Pathol2003120461061614560572
PubMed Web of Science ®Google Scholar
PetruzzielloFZeppaPCatalanoLAmyloid in bone marrow smears of patients affected by multiple myelomaAnn Hematol201089546947419894050
PubMed Web of Science ®Google Scholar
PetruzzielloFZeppaPCianciaGCytological and histological detection of amyloid deposits in bone marrow of patients affected by multiple myelomaLeuk Lymphoma201152122304230721718137
PubMed Web of Science ®Google Scholar
MadanSDispenzieriALacyMQClinical features and treatment response of light chain (AL) amyloidosis diagnosed in patients with previous diagnosis of multiple myelomaMayo Clin Proc201085323223820194151
PubMed Web of Science ®Google Scholar
SiragusaSMoriceWGertzMAAsymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literatureAnn Hematol201190110110620645101
PubMed Web of Science ®Google Scholar
DesikanKRDhodapkarMVHoughAIncidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantationLeuk Lymphoma1997273–43153199402328
PubMed Web of Science ®Google Scholar
WeiAJunejaSBone marrow immunohistology of plasma cell neoplasmsJ Clin Pathol200356640641112783964
PubMed Web of Science ®Google Scholar
LeeSHErberWNPorwitATomonagaMPetersonLCInternational Council for Standardization in HematologyICSH guidelines for the standardization of bone marrow specimens and reportsInt J Lab Hematol200830534936418822060
PubMed Web of Science ®Google Scholar
AbrahamRSGeyerSMPrice-TroskaTLImmunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL)Blood2003101103801380812515719
PubMed Web of Science ®Google Scholar
Vela-OjedaJGarcía-Ruiz EsparzaMAPadilla-GonzálezYMultiple myeloma-associated amyloidosis is an independent high-risk prognostic factorAnn Hematol2009881596618648809
PubMed Web of Science ®Google Scholar
BahlisNJLazarusHMMultiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?Bone Marrow Transplant200638171516715110
PubMed Web of Science ®Google Scholar
PalladiniGPerfettiVPerliniSThe combination of thalidomide and intermediate-dose dexamethasone is an effective but toxic treatment for patients with primary amyloidosis (AL)Blood200510572949295115572585
PubMed Web of Science ®Google Scholar
DispenzieriALacyMQRajkumarSVPoor tolerance to high doses of thalidomide in patients with primary systemic amyloidosisAmyloid200310425726114986485
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The risk of renal disease is increased in lambda myeloma with bone marrow amyloid deposits

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date